Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ResMed Inc. Common Stock
(NY:
RMD
)
224.03
+0.89 (+0.40%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ResMed Inc. Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
March 13, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
↗
February 08, 2023
Via
Benzinga
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
January 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
Hopeful Golden Cross Forms On ResMed's Chart
↗
January 26, 2023
Via
Benzinga
A Preview Of ResMed's Earnings
↗
January 25, 2023
Via
Benzinga
Where ResMed Stands With Analysts
↗
October 28, 2022
ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter:
Via
Benzinga
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
January 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
January 12, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
January 02, 2023
From
ResMed Inc.
Via
GlobeNewswire
Competitor Recall Continues To Show Opportunities For ResMed
↗
August 12, 2022
Via
Benzinga
Earnings Scheduled For August 11, 2022
↗
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Earnings Scheduled For January 26, 2023
↗
January 26, 2023
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report quarterly earnings at $0.14 per share on revenue of $7.20 billion.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
↗
January 17, 2023
Via
Benzinga
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
November 22, 2022
From
ResMed Inc.
Via
GlobeNewswire
Looking Into ResMed's Return On Capital Employed
↗
November 01, 2022
According to Benzinga Pro, during Q1, ResMed (NYSE:RMD) earned $210.48 million, a 7.9% increase from the preceding quarter. ResMed also posted a total of $950.29 million in sales, a 3.89% increase...
Via
Benzinga
Company Report Roundup: Tesla, Tractor Supply, American Express, and More
↗
October 29, 2022
Plus a look at investing books, stocks to watch, and other topics for investors.
Via
The Motley Fool
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
October 27, 2022
From
ResMed Inc.
Via
GlobeNewswire
Earnings Scheduled For October 27, 2022
↗
October 27, 2022
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
↗
October 20, 2022
Upgrades
Via
Benzinga
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
October 13, 2022
From
ResMed Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
↗
October 12, 2022
Upgrades
Via
Benzinga
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
↗
September 28, 2022
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.
Via
Investor's Business Daily
Hopeful Golden Cross Forms On ResMed's Chart
↗
September 22, 2022
If history is any guide, there may be good fortune ahead for shares of ResMed (NYSE:RMD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Via
Benzinga
Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout
↗
August 12, 2022
Tuesday marks the last chance for investors to receive the next dividend payout from ResMed (NYSE:RMD).
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,400 Today
↗
August 03, 2022
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 11.43% on an annualized basis producing an average annual return of 19.33%. Currently, ResMed has a market capitalization of...
Via
Benzinga
How Is The Market Feeling About ResMed?
↗
July 25, 2022
ResMed's (NYSE:RMD) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 1.39 million shares sold short, which is 0.96% of all...
Via
Benzinga
Semiconductor Shortages - See How ResMed Is Tackling
↗
July 22, 2022
ResMed Inc (NYSE: RMD) has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
↗
August 12, 2022
Via
Benzinga
Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today
↗
July 18, 2022
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 10.69% on an annualized basis producing an average annual return of 21.91%. Currently, ResMed has a market capitalization of...
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
